Market Overview - During the week from January 19 to January 23, A-shares showed mixed performance with the Shanghai Composite Index closing at 4136.16 points, up 0.83%, the Shenzhen Component Index at 14439.66 points, up 1.11%, and the ChiNext Index at 3349.50 points, down 0.34% [1] - Over 77% of stocks experienced gains during the week, with 237 stocks rising over 15%, while only 14 stocks fell more than 15% [1] - Sectors such as building materials, oil and petrochemicals, steel, and basic chemicals saw increases, while banking, telecommunications, non-bank financials, and food and beverage sectors declined [1] Top Gainers - *ST Lifan (300344.SZ) topped the weekly gainers with a remarkable 95.52% increase, followed by *ST Changyao (300391.SZ) with a 70.37% rise, and Fenglong Co. (002931.SZ) at 61.08% [2] - Other notable gainers included Zhizhi New Materials (300986.SZ) at 49.21%, Jiamei Packaging (002969.SZ) at 48.15%, and Hunan Silver (002716.SZ) at 47.44% [2] Company Profile of *ST Lifan - *ST Lifan is a digital technology cloud service provider focused on new digital infrastructure, with main business segments including intelligent hardware and software, digital intelligent services, and mobile information services [3] - The company's actual controller made unauthorized public statements that led to stock price fluctuations, prompting a clarification announcement from the company [3] Regulatory Concerns - On January 23, the Anhui Securities Regulatory Bureau reported that *ST Lifan faces a significant risk of forced delisting due to suspected false financial reporting for three consecutive years (2021, 2022, 2023) [4] - The company has been issued a notice regarding administrative penalties and market entry bans, and is currently in the process of appealing [4] - The regulatory body emphasized the importance of relying on official announcements from the company to avoid misinformation [4]

本报记者 吴晓璐 当日，已经连续3日涨停的*ST立方打开涨停板，收盘依旧上涨13.91%，4个交易日涨幅接近100%。类似情况也出现在同样 面临重大违法强制退市风险的长江医药控股股份有限公司（以下简称"*ST长药"）上。截至1月23日，该股连续4个交易日涨 停，累计涨幅达109.09%。1月23日晚间，*ST长药收到证监会《行政处罚决定书》，深交所也对公司下发《事先告知书》，决 定终止公司股票上市交易，其退市命运基本确定。 1月23日，安徽证监局发布关于立方数科股份有限公司（以下简称"*ST立方"）相关情况的通报，提醒*ST立方存在重大违 法强制退市风险，请广大投资者以公司正式公告内容为准，理性投资，避免被不实信息误导，造成损失。 华东政法大学国际金融法律学院教授郑彧对《证券日报》记者表示，在我国的证券监管体系下，所有涉及上市公司重大信 息均需要通过法定渠道披露，任何其他主体的公开性信息发布都可能构成违法，严重者甚至可能涉及操纵市场犯罪。 上海明伦律师事务所律师王智斌对《证券日报》记者表示，与退市有关的信息均属于重大信息，按照《上市公司信息披露 管理办法》第八条的规定，与公司有关的重大信息必须通过信披渠道发布 ...

1月23日，*ST长药收到中国证监会下发的《行政处罚决定书》。经查，*ST长药连续三年虚增收入和利 润，违反证券法律法规。证监会对上市公司罚款1000万元。 深交所1月23日公告，对因涉嫌财务数据存在虚假记载被证监会立案的"*ST立方""*ST长药"进行重点监 控。 公司同日发布关于公司股票停牌暨可能被终止上市的风险提示公告。 连续三年虚增收入和利润 经查明，2020年11月，*ST长药通过支付现金方式收购湖北长江星医药股份有限公司52.75%的股权。同 年12月，长江星纳入*ST长药财务报表合并范围。长江星原实际控制人罗明等对长江星2020年至2022年 净利润等指标进行了业绩承诺。上述收购完成后，罗明继续担任长江星董事长、总经理，全面负责长江 星的经营管理工作。 在收到《行政处罚事先告知书》不足一月后，*ST长药收到监管部门"罚单"。 同日，公司收到深圳证券交易所下发的《事先告知书》，公司触及《深圳证券交易所创业板股票上市规 则》第10.5.1条第一项、第10.5.2条第一款第六项规定的股票终止上市情形，深圳证券交易所拟决定终止 公司股票上市交易。根据《深圳证券交易所创业板股票上市规则》第10.1.5条规 ...

Core Viewpoint - *ST Changyao has been penalized by the China Securities Regulatory Commission (CSRC) for inflating revenue and profits for three consecutive years, resulting in a fine of 10 million yuan [1][5]. Group 1: Financial Misconduct - The company inflated its revenue by 215.32 million yuan, 283.74 million yuan, and 233.63 million yuan for the years 2021, 2022, and 2023 respectively, which accounted for 9.12%, 17.57%, and 19.51% of the reported revenue for those years [3]. - The inflated profit totals were 56.40 million yuan, 63.38 million yuan, and 43.71 million yuan for the same years, representing 35.62%, 88.23%, and 6.42% of the reported profit [3]. - In addition, the company failed to reasonably recognize losses related to a project in 2022, leading to an additional profit inflation of 4.55 million yuan, which was 6.34% of the reported profit for that year [4]. Group 2: Regulatory Actions - On January 23, the company received a notice from the CSRC regarding administrative penalties, which included a warning and a fine of 10 million yuan [5]. - The Shenzhen Stock Exchange has announced that it will monitor *ST Changyao closely due to the financial misconduct and is considering terminating the company's stock listing [1][6]. - The company has triggered major violations that could lead to mandatory delisting, as it has reported false financial data for three consecutive years [6][7]. Group 3: Market Implications - The recent actions by regulatory bodies reflect a zero-tolerance policy towards financial fraud, aiming to enhance the overall quality of listed companies and improve the investment environment [10]. - The stock price of *ST Changyao has seen a surge, with four consecutive days of trading limits, indicating market speculation despite the impending regulatory actions [10].

格隆汇1月23日丨*ST长药（维权）(300391.SZ)公布，公司收到中国证监会下发的《决定书》，认定公 司2021年、2022年、2023年年度报告存在虚假记载，公司触及《深圳证券交易所创业板股票上市规则》 第10.5.1条第一项、第10.5.2条第一款第六项的"根据中国证监会行政处罚决定载明的事实，公司披露的 年度报告财务指标连续三年存在虚假记载，前述财务指标包括营业收入、利润总额、净利润、资产负债 表中的资产或者负债科目"的重大违法强制退市情形，公司股票可能被终止上市。根据《深圳证券交易 所创业板股票上市规则》第10.1.5条规定，上市公司出现两项以上终止上市情形的，其股票按照先触及 先适用的原则实施终止上市，目前公司已先触及重大违法强制退市情形。 根据《深圳证券交易所创业板股票上市规则》第10.5.8条相关规定，公司股票自2026年1月26日（星期 一）开市起停牌。根据第10.5.10条规定：公司收到终止上市事先告知书后，可以根据"第十章退 市"之"第六节听证与复核"的规定申请听证，提出陈述和申辩。公司未在规定期限内提出听证申请的， 深圳证券交易所上市委员会在陈述和申辩提交期限届满后十五个交易日内， ...

【导读】安徽证监局发布关于 *ST 立方相关情况的通报 中国基金报记者 忆山 1 月 23 日，安徽证监局发布关于立方数科股份有限公司（以下简称 *ST 立方）相关情况的 通报，提醒 *ST 立方存在重大违法强制退市风险，请广大投资者以公司正式公告内容为准， 理性投资，避免被不实信息误导，造成损失。 股票复牌后涨超 95% 1 月 18 日、 20 日， *ST 立方实控人古某瑭通过媒体发布《致立方数科全体股东的公开 信》《 *ST 立方回应风险提示：多措并举应对挑战 股票 20 日复牌》，公司股价于 1 月 20 日涨停。 安徽证监局：将依法开展监管处置 安徽证监局在 通报中表 示， *ST 立方因 2021 年、 2022 年、 2023 年连续三年年度报告 财务数据涉嫌虚假记载，触及《创业板股票上市规则》关于重大违法强制退市情形的规定， 公司股票可能被强制退市，安徽证监局已于 2025 年 11 月 28 日下发《行政处罚及市场禁 入事先告知书》。 根据告知书， *ST 立方连续三年虚增收入和成本，严重违反证券法律法规，安徽证监局拟对 *ST 立方处以 1000 万元罚款，对汪逸等 10 名责任人合计罚 ...

安徽证监局指出，*ST立方因2021年、2022年、2023年连续三年年度报告财务数据涉嫌虚假记载，触及《创业板股票上市规则》关于重大违法强制退市情形 的规定，股票可能被强制退市，安徽证监局已于2025年11月28日下发《行政处罚及市场禁入事先告知书》。 安徽证监局郑重提醒，*ST立方存在重大违法强制退市风险，请广大投资者以该公司正式公告内容为准，理性投资，避免被不实信息误导，造成损失。 1月23日，安徽证监局发布关于*ST立方相关情况的通报。 近期，安徽证监局关注到有人通过媒体发布《*ST立方回应风险提示：多措并举应对挑战 股票20日复牌》等信息，涉嫌存在不真实、不准确、不完整情形和 误导性陈述，*ST立方已通过法定渠道予以公告澄清，安徽证监局也将依法开展监管处置。 *ST立方向安徽证监局提出延期申辩和听证的申请，安徽证监局已依法准予延期，目前正抓紧开展相关工作。后续，安徽证监局将依法做出行政处罚决定。 *ST立方实控人古某瑭1月18日、20日通过媒体发布《致立方数科全体股东的公开信》《*ST立方回应风险提示：多措并举应对挑战股票20日复牌》，*ST立 方股价于1月20日应声涨停。 1月20日午间，*ST立 ...

1月23日，安徽证监局发布关于*ST立方（300344）相关情况的通报。 根据通报内容，*ST立方因2021年、2022年、2023年连续三年年度报告财务数据涉嫌虚假记载，触及《创业板股票上市规则》关于重大违法强制退市情形 的规定，公司股票可能被强制退市，安徽证监局已于2025年11月28日下发《行政处罚及市场禁入事先告知书》。 *ST立方向安徽证监局提出延期申辩和听证的申请，安徽证监局已依法准予延期，目前正抓紧开展相关工作。后续，安徽证监局将依法做出行政处罚决 定。 | 索 引 号 | bm56000001/2026-00000845 | 分 类 | 通知公告; | | --- | --- | --- | --- | | 发布机构 | | 发文日期 | 2026年01月23日 | | 名 称 | 关于*ST立方相关情况的通报 | | | | 文 号 | | 主题词 | | 此前，*ST立方因定期报告涉嫌信息披露违法违规， 被中国证监会立案调查。 2025年11月28日，安徽证监局向*ST立方下发《行政处罚及市场禁入事先告知书》。根据告知书认定的事实，2021年至2023年，*ST立方通过开展代理业 务、融资 ...

Core Viewpoint - The article discusses the regulatory actions and financial misconduct associated with *ST Lifan, highlighting the risks of forced delisting due to significant financial misreporting and misleading public statements by the company's actual controller [1][3]. Regulatory Actions - The Anhui Securities Regulatory Bureau has issued a notice regarding *ST Lifan, indicating that misleading information was disseminated through media by the actual controller, Gu Yutang, which led to a temporary surge in the company's stock price [1][3]. - Following the misleading statements, *ST Lifan clarified that the board was unaware of the reports and did not authorize them, leading to disciplinary actions against Gu Yutang by the Shenzhen Stock Exchange [5][6]. Financial Misconduct - *ST Lifan has been flagged for three consecutive years of financial misreporting, with the potential for forced delisting due to violations of the Shenzhen Stock Exchange's listing rules [6][9]. - The company reported inflated revenues and costs for the years 2021 to 2023, with significant discrepancies: - In 2021, inflated revenue was 280 million, accounting for 50.09% of total revenue, and inflated costs were 277 million, making up 60.61% of total costs [8]. - In 2022, inflated revenue was 312 million, representing 51.67% of total revenue, and inflated costs were 305 million, or 53.54% of total costs [8]. - In 2023, inflated revenue was approximately 45.87 million, which was 24.00% of total revenue, and inflated costs were about 45.23 million, accounting for 27.55% of total costs [8]. Potential Penalties - The Anhui Securities Regulatory Bureau plans to impose a fine of 10 million on *ST Lifan and issue warnings to the responsible individuals, totaling 30 million in fines, along with a 10-year market ban for three key personnel [8][9].

Core Viewpoint - The Anhui Securities Regulatory Commission has issued a notice regarding *ST Lifan (300344.SH), highlighting concerns over misleading statements made by the company's actual controller, Gu Yutang, which led to a significant stock price increase. The company faces a major risk of forced delisting due to serious violations of financial reporting regulations [1][3]. Group 1: Misleading Statements and Stock Price Impact - The Anhui Securities Regulatory Commission noted that misleading information was disseminated through media by Gu Yutang, resulting in a stock price surge on January 20, 2023, when *ST Lifan's shares hit the daily limit [1][2]. - Following the misleading statements, *ST Lifan issued a clarification on January 20, stating that the board was unaware of the reports and did not authorize their release [2]. - The Shenzhen Stock Exchange has initiated disciplinary procedures against Gu Yutang for his actions, which are deemed to have violated disclosure regulations [2]. Group 2: Financial Misconduct and Regulatory Actions - *ST Lifan has been flagged for three consecutive years of financial data misrepresentation, which could lead to forced delisting under the Shenzhen Stock Exchange's rules [3][5]. - The company has been accused of inflating revenue and costs significantly in its financial reports for 2021, 2022, and 2023, with inflated revenues of 280 million yuan (50.09% of 2021 revenue), 312 million yuan (51.67% of 2022 revenue), and 45.87 million yuan (24.00% of 2023 revenue) [4]. - The Anhui Securities Regulatory Commission plans to impose a fine of 10 million yuan on *ST Lifan and issue warnings to the responsible individuals, with potential market bans for three key personnel [5].